EU drugs watchdog expects first application for marketing approval of COVID-19 vaccine in days

EU drugs watchdog expects first application for marketing approval of COVID-19 vaccine in days

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a
FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on Apr 10, 2020. (Photo: REUTERS/Dado Ruvic)

BRUSSELS: Europe's drugs watchdog said on Thursday (Nov 26) it expects to receive the first application for conditional marketing approval for a COVID-19 vaccine "in the coming days", the latest step towards making a shot available outside the United States.

The European Medicines Agency (EMA) did not name the company it expects to file the application, but Pfizer and BioNTEch are the most advanced in the regulatory process among the three companies that have published late-stage trial data for their vaccines.

READ: Pfizer says early data signals COVID-19 vaccine is 90% effective

READ: Moderna to charge US$25 to US$37 for COVID-19 vaccine

The companies applied on Nov 20 for US approval and the UK said it has asked its medical regulator to assess the vaccine for its suitability.

Asked about its co-operation with the US Food and Drug Administration (FDA), it said in an email the agency may not be able to synchronise the decision making process with other international regulators.

READ: After year-long sprint, COVID-19 vaccines finally at hand

The EMA started a real-time review of the Pfizer-BioNTech vaccine on Oct  6 to speed up the process of approving a successful vaccine in the bloc, by allowing researchers to submit findings in real time, 

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram​​​​​​

without waiting for studies to conclude. 

Source: /ga

Bookmark